Skip to main content
Log in

Association of Polymorphic Variants of TCF7L2 and PPARG Genes with Metabolic Markers in Patients with Early Disorders of Carbohydrate Metabolism

  • Published:
Bulletin of Experimental Biology and Medicine Aims and scope

We performed complex analysis of the association of polymorphic variants rs7903146 of the TCF7L2 gene and rs1801282 of the PPARG gene with metabolic parameters, insulin resistance, and β-cell function in a group of patients with early signs of carbohydrate metabolism disturbances in a sample of Tyumen citizens. The study group consisted of 64 people (39 women, 25 men) aged 40-70 years. The distribution of frequencies of alleles and genotypes of the polymorphic markers rs7903146 and rs1801282 was analyzed and associations of carriage of major homozygous polymorphisms with various phenotypic traits were identified. Genotyping for polymorphic variants of TCF7L2 and PPARG genes was performed using allele-specific PCR with primers provided by Synthol company. Carriers of homozygotes for allele C of the polymorphic marker rs7903146 significantly differed from other respondents by a higher level of C-peptide, as well as by the presence of associations with waist circumference, elevated level of glycated hemoglobin, and arterial hypertension. Carriers of homozygotes for the allele C of the rs1801282 polymorphism of the PPARG gene differed from the group of carriers of homozygotes for the allele G and the group of heterozygote carriers by higher levels of triglycerides, as well as the presence of associations with waist circumference and the level of glycated hemoglobin.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Valeeva FV, Medvedeva MS, Kiseleva TA, Khasanova KB, Gabidinova GF. Association of rs7903146 TCF7L2, rs1042714 ADRB2 with the changes in body fat mass in different types of therapy of early carbohydrate metabolism disorders. Ozhirenie Metabolizm. 2022;19(1):7-18. Russian. https://doi.org/10.14341/omet12807

  2. Vlasova SA, Azisova EM, Isakova DN, Kurmangulov AA. Difficulties of diagnostic of carbohydrate metabolism disorders in primary health care. Med. Nauka Obrazovanie Urala. 2020;21(2):87-90. Russian. https://doi.org/10.36361/1814-8999-2020-21-2-87-90

  3. Geoghegan G, Simcox J, Seldin MM, Parnell TJ, Stubben C, Just S, Begaye L, Lusis AJ, Villanueva CJ. Targeted deletion of Tcf7l2 in adipocytes promotes adipocyte hypertrophy and impaired glucose metabolism. Mol. Metab. 2019;24:44-63. https://doi.org/10.1016/j.molmet.2019.03.003

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  4. Yi F, Brubaker PL, Jin T. TCF-4 mediates cell type-specific regulation of proglucagon gene expression by beta-catenin and glycogen synthase kinase-3beta. J. Biol. Chem. 2005;280(2):1457-1464. https://doi.org/10.1074/jbc.M411487200

    Article  CAS  PubMed  Google Scholar 

  5. Zhou Y, Park SY, Su J, Bailey K, Ottosson-Laakso E, Shcherbina L, Oskolkov N, Zhang E, Thevenin T, Fadista J, Bennet H, Vikman P, Wierup N, Fex M, Rung J, Wollheim C, Nobrega M, Renström E, Groop L, Hansson O. TCF7L2 is a master regulator of insulin production and processing. Hum. Mol. Genet. 2014;23(24):6419-6431. https://doi.org/10.1093/hmg/ddu359

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  6. Nikitin AG, Potapov VA, Brovkin AN, Lavrikova EYu, Khodyrev DS, Shamhalova MSh, Smetanina SA, Suplotova LA, Shestakova MV, Nosikov VV, Averyanov AV. Association of the polymorphisms of the TCF7L2 genes with type 2 diabetes. Klin. Prakt. 2014;5(1):4-11. Russian. https://doi.org/10.17816/clinpract514-11

  7. Grant SF, Thorleifsson G, Reynisdottir I, Benediktsson R, Manolescu A, Sainz J, Helgason A, Stefansson H, Emilsson V, Helgadottir A, Styrkarsdottir U, Magnusson KP, Walters GB, Palsdottir E, Jonsdottir T, Gudmundsdottir T, Gylfason A, Saemundsdottir J, Wilensky RL, Reilly MP, Rader DJ, Bagger Y, Christiansen C, Gudnason V, Sigurdsson G, Thorsteinsdottir U, Gulcher JR, Kong A, Stefansson K. Variant of transcription factor 7-like 2 (TCF7L2) gene confers risk of type 2 diabetes. Nat. Genet. 2006;38(3.):320-323. https://doi.org/10.1038/ng1732

  8. Cauchi S, El Achhab Y, Choquet H, Dina C, Krempler F, Weitgasser R, Nejjari C, Patsch W, Chikri M, Meyre D, Froguel P. TCF7L2 is reproducibly associated with type 2 diabetes in various ethnic groups: a global meta-analysis. J. Mol. Med. (Berl). 2007;85(7):777-782. https://doi.org/10.1007/s00109-007-0203-4

    Article  CAS  PubMed  Google Scholar 

  9. Valeeva FV, Kiseleva TA, Khasanova KB, Akhmetov II, Valeeva EV, Nabiullina RM. Analysis of associations of polymorphous markers of TCF7L2 gene with diabetes mellitus of the 2nd type in the case of residents of the republic of Tatarstan. Med. Almanakh. 2017;(6):126-129. Russian.

  10. Romantsova TI. The obesity epidemic: obvious and probable causes. Ozhirenie Metabolizm. 2011;8(1):5-19. Russian. https://doi.org/10.14341/2071-8713-5186

  11. Kovtun OP, Ustyuzhanina MA. Polymorphism of PPARG (P12A), APOA1 (G75A), and APOE (C112A and A158C) genes in children with obesity and arterial hypertension: a case—control study. Voprosy Sovrem. Med. 2018;17(4):307-315. Russian. https://doi.org/10.15690/vsp.v17i4.1924

  12. Ievleva KD, Bairova TA, Sheneman EA, Ayurova ZhG, Bugun OV, Rychkova LV, Kolesnikova LI, Bal’zhieva VV, Novikova EA. The protective effect of G-allele of PPARG2 rs1801282 polymorphism against overweight and obesity in mongoloid adolescents. Zh. Med.-Biol. Issled. 2019;7(4):452-463. Russian. https://doi.org/10.17238/issn2542-1298.2019.7.4.452

  13. Bondar IA, Filipenko ML, Shabelnikova OY, Sokolova EA. Association between gene PPARG rs1801282 PRO12ALA and type 2 diabetes in Novosibirsk region and other populations. Sib. Med. Zh. (Tomsk). 2014;29(2):75-78. Russian. https://doi.org/10.29001/2073-8552-2014-29-2-75-78

  14. Kilpeläinen TO, Lakka TA, Laaksonen DE, Lindström J, Eriksson JG, Valle TT, Hämäläinen H, Ilanne-Parikka P, Keinänen-Kiukaanniemi S, Lindi V, Tuomilehto J, Uusitupa M, Laakso M. SNPs in PPARG associate with type 2 diabetes and interact with physical activity. Med. Sci. Sports Exerc. 2008;40(1):25-33. https://doi.org/10.1249/mss.0b013e318159d1cd

    Article  CAS  PubMed  Google Scholar 

  15. Deeb SS, Fajas L, Nemoto M, Pihlajamäki J, Mykkänen L, Kuusisto J, Laakso M, Fujimoto W, Auwerx J. A Pro12Ala substitution in PPARgamma2 associated with decreased receptor activity, lower body mass index and improved insulin sensitivity. Nat. Genet. 1998;20(3):284-287. https://doi.org/10.1038/3099

    Article  CAS  PubMed  Google Scholar 

  16. Thorsby PM, Midthjell K, Gjerlaugsen N, Holmen J, Hanssen KF, Birkeland KI, Berg JP. Comparison of genetic risk in three candidate genes (TCF7L2, PPARG, KCNJ11) with traditional risk factors for type 2 diabetes in a population-based study — the HUNT study. Scand. J. Clin. Lab Invest. 2009;69(2):282-287. https://doi.org/10.1080/00365510802538188

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to D. N. Isakova.

Additional information

Translated from Byulleten’ Eksperimental’noi Biologii i Meditsiny, Vol. 176, No. 10, pp. 482-487, October, 2023

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Isakova, D.N., Kolomeichuk, S.N., Petrova, Y.A. et al. Association of Polymorphic Variants of TCF7L2 and PPARG Genes with Metabolic Markers in Patients with Early Disorders of Carbohydrate Metabolism. Bull Exp Biol Med 176, 481–485 (2024). https://doi.org/10.1007/s10517-024-06051-w

Download citation

  • Received:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10517-024-06051-w

Keywords

Navigation